Hans Lilja

Pulmonary and Respiratory Medicine · 2005–2019

A researcher in the Science corpus: 9 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom Hans Lilja trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. P. Walsh
  2. A. Jemal

Who trusts Hans Lilja overall

  1. M. Shen

Papers from Hans Lilja's perspective

Ordered by how strongly the researchers Hans Lilja trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up. (Journal of the National Cancer Institute)
  2. MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis (New England Journal of Medicine)
  3. Circulating Tumor Cells versus Imaging—Predicting Overall Survival in Metastatic Breast Cancer (Clinical Cancer Research)
  4. Radical prostatectomy versus watchful waiting in early prostate cancer. (Journal of Urology)
  5. The Statistical Analysis of Failure Time Data (Technometrics)
  6. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. (The Lancet)
  7. Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer. (Journal of Clinical Oncology)
  8. Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. (Journal of the National Cancer Institute)
  9. Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower. (Journal of the American Medical Association (JAMA))
  10. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. (Journal of the American Medical Association (JAMA))

Their papers